Bureaucrats, checkuser, developer, editor, reviewer, Administrators, widgeteditor
1,951
edits
Changes
Created page with '{{Drug | name = chlordiazepoxide | type = benzodiazepine | group = benzodiazepine | CAS = 58-25-3 | ChemSpiderID = 10248513 | ATC = N05BA02 | pubchem = 2712 | DrugBank = APRD0068...'
{{Drug
| name = chlordiazepoxide
| type = benzodiazepine
| group = benzodiazepine
| CAS = 58-25-3
| ChemSpiderID = 10248513
| ATC = N05BA02
| pubchem = 2712
| DrugBank = APRD00682
| medscape = 8630
| drugscom = chlordiazepoxide
| ftk = chloordiazepoxide
| equivalent = 0.5
| equivalent_ref = <ref>{{KNMPgener|Benzodiazepineagonisten}}</ref>
| comparison = diazepam
| avail = 100
| avail_ref = <ref>Boxenbaum HG, Geitner KA, Jack ML et al; Pharmacokinetic and Biopharmaceutic Profile of Chlordiazepoxide HCl in Healthy Subjects: Single-Dose Studies by the Intravenous, Intramuscular, and Oral Routes; ''J Pharmacokinet Biopharm'' 1977;'''5''':3-23</ref>
| halflife = 9
| halflife_ref = <ref name="drugs">{{DRUGSCOM|chloordiazepoxide}}</ref> <ref name="informatorium">{{KNMP|chloordiazepoxide}}</ref>
| ct = 22
| ct_ref = <ref>{{pts}}</ref>
| metabolites = 10
| metabolites_ref = <ref name="drugs" /><ref name="informatorium" />
| administration = oral, IM
| administration_ref = <ref name="drugs" /><ref name="informatorium" />
| dose = 5-100
| dose_ref = <ref name="informatorium" /> <ref name="drugs" />
| DDD = 30
| DDD_ref = <ref>{{WHOCC|N05BA02}}</ref>
| ctox = 3500 - 10000
| ctox_ref = <ref>{{Toxicology|29}}</ref>
| <includeonly> isswitch = 1 </includeonly>
}}
| name = chlordiazepoxide
| type = benzodiazepine
| group = benzodiazepine
| CAS = 58-25-3
| ChemSpiderID = 10248513
| ATC = N05BA02
| pubchem = 2712
| DrugBank = APRD00682
| medscape = 8630
| drugscom = chlordiazepoxide
| ftk = chloordiazepoxide
| equivalent = 0.5
| equivalent_ref = <ref>{{KNMPgener|Benzodiazepineagonisten}}</ref>
| comparison = diazepam
| avail = 100
| avail_ref = <ref>Boxenbaum HG, Geitner KA, Jack ML et al; Pharmacokinetic and Biopharmaceutic Profile of Chlordiazepoxide HCl in Healthy Subjects: Single-Dose Studies by the Intravenous, Intramuscular, and Oral Routes; ''J Pharmacokinet Biopharm'' 1977;'''5''':3-23</ref>
| halflife = 9
| halflife_ref = <ref name="drugs">{{DRUGSCOM|chloordiazepoxide}}</ref> <ref name="informatorium">{{KNMP|chloordiazepoxide}}</ref>
| ct = 22
| ct_ref = <ref>{{pts}}</ref>
| metabolites = 10
| metabolites_ref = <ref name="drugs" /><ref name="informatorium" />
| administration = oral, IM
| administration_ref = <ref name="drugs" /><ref name="informatorium" />
| dose = 5-100
| dose_ref = <ref name="informatorium" /> <ref name="drugs" />
| DDD = 30
| DDD_ref = <ref>{{WHOCC|N05BA02}}</ref>
| ctox = 3500 - 10000
| ctox_ref = <ref>{{Toxicology|29}}</ref>
| <includeonly> isswitch = 1 </includeonly>
}}
